Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2025Epilepsy & Behavior ReportsOpen Access

Late-onset unexplained epilepsy with dual amyloid and tau negativity: are alpha-synuclein seed amplification assays the next diagnostic step?

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAugustin MoreauÉRÉlisabeth Ruppert‪B‪Frederic Blanc‬

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moreau et al. (2025) studied this question.

synapsesocial.com/papers/6aa92da104014c9901263af8https://doi.org/10.1016/j.ebr.2025.100783
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation2024 · 32 citations
  2. 2Bi-directional association between epilepsy and dementia2020 · 94 citations
  3. 3Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology2023 · 35 citations
  4. 4Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort2024 · 38 citations
  5. 5Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024 · 2,686 citations